TG Therapeutics Inc (TGTX)
Debt-to-assets ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | 244,429 | 100,118 | 71,135 | 66,788 | 7,716 |
| Total assets | US$ in thousands | 577,690 | 329,587 | 193,572 | 379,629 | 625,642 |
| Debt-to-assets ratio | 0.42 | 0.30 | 0.37 | 0.18 | 0.01 |
December 31, 2024 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $244,429K ÷ $577,690K
= 0.42
The debt-to-assets ratio of TG Therapeutics Inc has shown a steady increase over the past five years, starting at a very low 0.01 in December 31, 2020, and reaching 0.42 by December 31, 2024. This indicates that the company's proportion of debt in relation to its total assets has been growing consistently over time.
The ratio's upward trend suggests that TG Therapeutics Inc has been relying more on debt financing compared to its total assets. This may indicate that the company has been taking on more debt to finance its operations, investments, or expansion strategies.
A higher debt-to-assets ratio generally implies higher financial risk, as the company may have more obligations to meet in the form of debt repayments, which could potentially strain its financial resources in the future. It is important for investors and creditors to monitor this ratio closely, as a significantly high ratio could signal potential financial distress for the company.
Peer comparison
Dec 31, 2024